EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Interleukin-1β and cancer immune response

Cédric Rébé, François Ghiringhelli

Seminars in Immunology · 2025-12 · 80 · 102002

DOI: 10.1016/j.smim.2025.102002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Immunology, 2025-12. Verfasst von Cédric Rébé und 1 weiteren Autor:innen. Beteiligte Einrichtung: Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Cancer Biology Transfer Platform, UMR INSERM 1231, TIRECs team, Equipe Label…. Hauptthemen laut MEDLINE: Neoplasms, Interleukin-1beta. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation ARC pour la Recherche sur Le Cancer, Institut National Du Cancer, Ligue Contre le Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IL-1β belongs to the IL-1 family and has the particularity to need to be cleaved by caspase-1 to be active. Once processed, IL-1β is secreted and binds to IL-1R1 on target cells, leading to the transcription of specific genes. Within a tumor, IL-1β is produced and secreted by various cell types, such as immune cells, fibroblasts or cancer cells and has pleiotropic effects on immune cells, angiogenesis, cancer cell proliferation, migration and metastasis. Thus, depending on the cancer type, the treatments or the tumor microenvironment (TME), IL-1β has opposite effects on cancer progression, thus raising the question of inducing or inhibiting IL-1β. Here, we will analyze the impact of IL-1β on cancer cells and immune cells of the TME in different types of cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsInterleukin-1betaHumansTumor MicroenvironmentAnimalsSignal Transduction

Stichwörter der Autor:innen

CancerIL-1βImmune cellsInflammasomes

Substanzen

Interleukin-1beta

Autor:innen und Institutionen

  • Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Cancer Biology Transfer Platform, UMR INSERM 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon 21000, France. Electronic address: crebe@cgfl.…
  • Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Cancer Biology Transfer Platform, UMR INSERM 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon 21000, France. Electronic address: fghiringhel…

Förderung

  • Fondation ARC pour la Recherche sur Le Cancer
  • Institut National Du Cancer
  • Ligue Contre le Cancer
  • Association pour la Recherche sur le Cancer

Zitieren

APA

Rébé, C., & Ghiringhelli, F. (2025). Interleukin-1β and cancer immune response. Seminars in Immunology, 80, 102002. https://doi.org/10.1016/j.smim.2025.102002

Vancouver

Rébé C, Ghiringhelli F. Interleukin-1β and cancer immune response. Seminars in Immunology. 2025;80:102002. doi:10.1016/j.smim.2025.102002

BibTeX
@article{Rb2025,
  author = {Rébé, Cédric and Ghiringhelli, François},
  title = {Interleukin-1β and cancer immune response},
  journal = {Seminars in Immunology},
  year = {2025},
  volume = {80},
  pages = {102002},
  doi = {10.1016/j.smim.2025.102002}
}
Kostenlos starten →